发明名称 Novel chimeric CD154
摘要 The present invention provides for an isolated polynucleotide sequence encoding a chimeric CD154, comprising a first nucleotide sequence encoding an extracellular subdomain of non-human CD154, preferably murine CD154, that replaces a cleavage site of human CD154, and a second nucleotide sequence encoding an extracellular subdomain of human CD154 that binds to a human CD154 receptor. The first nucleotide sequence preferably further encodes an extracellular subdomain of non-human CD154 that is critical for expression of said CD154 by cells, such as human CD40+ cells, and another extracellular domain that detects expression of the chimeric CD154 by binding to anti-murine antibodies. The second nucleotide sequence preferably further encodes an extracellular subdomain of human CD154 to which functionally inhibitory anti-CD154 antibodies bind. The present invention also provides for the chimeric CD154 that is encoded by the above-described polynucleotide sequence, an expression vector and a genetic vector comprising the polynucleotide sequence, a host cell comprising the expression vector or the genetic vector, a process for producing the chimeric CD154, and methods for utilizing the expression vectors and genetic constructs containing the chimeric CD154 polynucleotide sequences.
申请公布号 US2003220473(A1) 申请公布日期 2003.11.27
申请号 US20020154759 申请日期 2002.05.23
申请人 PRUSSAK CHARLES E.;KIPPS THOMAS J.;CANTWELL MARK J. 发明人 PRUSSAK CHARLES E.;KIPPS THOMAS J.;CANTWELL MARK J.
分类号 C12N15/09;A61K38/00;A61K39/00;A61K48/00;A61P35/00;C07K14/705;C07K19/00;C12N5/10;C12P21/02;G01N33/50;(IPC1-7):G01N33/53;A61K39/395;C07H21/04;C07K14/74;C12N5/06 主分类号 C12N15/09
代理机构 代理人
主权项
地址